Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0238 Transporter Info | ||||
Gene Name | SLC27A1 | ||||
Transporter Name | Fatty acid transport protein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Approved Drug |
|||||
Tolcapone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tolcapone induces the transportation of Palmitate by increasing mRNA expression of SLC27A1 | [1] | |||
Affected Drug/Substrate |
Palmitate | Modulation Type | Inducer | ||
Cell System |
Human hepatoma HepaRG cells | ||||
Alitretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Alitretinoin increases the expression of SLC27A1 | [3] | |||
Methotrexate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Methotrexate inhibits the expression of SLC27A1 | [4] | |||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Copper Sulfate increases the expression of SLC27A1 | [5] | |||
Zoledronic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Zoledronic Acid increases the expression of SLC27A1 | [6] | |||
Calcitriol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Calcitriol increases the expression of SLC27A1 | [7] | |||
Testosterone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Testosterone increases the expression of SLC27A1 | [7] | |||
Cisplatin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cisplatin affects the expression of SLC27A1 | [8] | |||
Decitabine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Decitabine affects the expression of SLC27A1 | [8] | |||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Urethane increases the expression of SLC27A1 | [9] | |||
Doxorubicin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Doxorubicin inhibits the expression of SLC27A1 | [10] | |||
Temozolomide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Temozolomide increases the expression of SLC27A1 | [11] | |||
Ivermectin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Ivermectin inhibits the expression of SLC27A1 | [12] | |||
Rosiglitazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Rosiglitazone inhibits the expression of SLC27A1 | [13] | |||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Valproic Acid increases the expression of SLC27A1 | [14] | |||
Drug in Phase 2 Trial |
|||||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Bisphenol A increases the expression of SLC27A1 | [20] | |||
Drug in Phase 1 Trial |
|||||
Trichostatin A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Trichostatin A affects the expression of SLC27A1 | [19] | |||
Investigative Drug |
|||||
Lipofermata |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lipofermata inhibits the transportation of Lipid by SLC27A1 | [2] | |||
Affected Drug/Substrate |
Lipid | Modulation Type | Inhibition | ||
Cell System |
A375 and SKMel28 cells-FATP1 | ||||
Natural Product |
|||||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tobacco Smoke Pollution inhibits the expression of SLC27A1 | [18] | |||
Traditional Medicine |
|||||
Jinfukang |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Jinfukang increases the expression of SLC27A1 | [17] | |||
Environmental toxicant |
|||||
Polychlorinated dibenzodioxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Polychlorinated dibenzodioxin affects the expression of SLC27A1 | [16] | |||
Health and Environmental Toxicant |
|||||
Lead |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Lead inhibits the expression of SLC27A1 | [15] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.